Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight
View original at finance.yahoo.comAlopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight The alopecia areata market is expected to grow significantly as awareness of the condition increases, potentially expanding further in the coming years, s…
What we drew from this source
The claims Via News extracted from this document. We point to the source; we don't replace it.
The total alopecia areata treatment market size is expected to grow positively by 2036 in the leading markets
80% confidenceDespite advancements, a substantial unmet need persists, as currently available treatments do not consistently deliver durable or complete disease control across patient populations
80% confidenceIn 2025, the total diagnosed prevalent cases of alopecia areata in the 7MM were found to be 1.7 million
80% confidenceThe entry of new therapies under development is expected to intensify competition and may reduce the market share of established treatments like LITFULO and OLUMIANT over time
80% confidenceThe United States accounts for the largest market size of alopecia areata, in comparison to EU4, the UK, and Japan
80% confidenceA limited number of therapies are currently approved for the treatment of alopecia areata, underscoring the field's strong emphasis on immune-modulating mechanisms
80% confidenceIn 2024, the United States recorded approximately 620K diagnosed cases of alopecia areata
80% confidencePrevalent cases of alopecia areata in the US accounted for nearly 35% of cases in the 7MM
80% confidence